DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 04 · Volume 33 · November 2013 DOI: 10.1055/s-003-25902 Lipids and the Liver Guest Editor, David E. Cohen, MD, PhD

Foreword

  • 299
    Cohen, David E.:

    Lipids and the Liver

  • 301
    Xu, Xu; So, Jae-Seon; Park, Jong-Gil; Lee, Ann-Hwee:

    Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP

  • 312
    Goh, Vera J.; Silver, David L.:

    The Lipid Droplet as a Potential Therapeutic Target in NAFLD

  • 321
    Henkel, Anne; Green, Richard M.:

    The Unfolded Protein Response in Fatty Liver Disease

  • 330
    Fuchs, Claudia; Claudel, Thierry; Trauner, Michael:

    Bile Acid-Mediated Control of Liver Triglycerides

  • 343
    Mells, Jamie Eugene; Anania, Frank A.:

    The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism

  • 358
    Schaefer, Esperance A.K.; Chung, Raymond T.:

    HCV and Host Lipids: An Intimate Connection

  • 369
    Krawczyk, Marcin; Portincasa, Piero; Lammert, Frank:

    PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease

  • 380
    Cohen, David E.; Fisher, Edward A.:

    Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

    • Diagnostic Problems in Hepatology

  • 389
    Ding, Xianzhong; Thung, Swan N.; Grewal, Priya:

    Steatohepatitis Secondary to Long-Term Glucocorticoid Treatment for Congenital Adrenal Hyperplasia: A Potential Diagnostic Pitfall